Skip to content

艾瑞思姆科技

US · IRTC #2372 按市值排名 上市于 2016
108.66 -0.69 -0.63%
实时 - 追踪5344个代码 - 心跳于20秒前 · 2026-10-16 19:30

✦ 量化财务健康度 计算方式说明

一般
  • 奥特曼 Z 值为2.58,处于1.8至3.0的"灰色区"。
  • 该模型对工业和制造业公司最为可靠,对银行、保险等金融类公司参考意义较弱。

营收 年度数据,近8年

最近年度同比+26.24%

利润率

毛利率
70.57%
营业利润率
-7.09%
净利率
-5.96%

关键比率与质量指标

奥特曼 Z 值低于约1.8提示财务困境风险,高于约3.0提示风险较低;该模型对工业和制造业公司最为可靠,对银行等金融类公司参考意义较弱。

利润表

项目 2018 2019 2020 2021 2022 2023 2024 2025
营收 147.28M214.55M265.17M322.83M410.92M492.68M591.84M747.14M
毛利润 108.48M162.07M194.89M213.57M281.63M331.81M407.53M527.25M
销售及管理费用 133.31M179.52M197.23M274.84M322.20M385.65M418.57M492.55M
研发费用 20.86M37.30M41.33M38.67M46.61M60.24M103.83M87.65M
营业利润 -45.69M-54.76M-43.67M-99.94M-87.18M-114.08M-114.86M-52.95M
税前利润 -50.33M-54.50M-43.60M-100.99M-115.89M-122.66M-112.72M-43.60M
税费 44.00K65.00K229.00K367.00K269.00K750.00K565.00K953.00K
净利润 -50.38M-54.57M-43.83M-101.36M-116.16M-123.41M-113.29M-44.55M
基本每股收益 -2-2-2-3-4-4-4-1
稀释每股收益 -2.11-2.16-1.58-3.46-3.88-4.04-3.63-1.39

资产负债表

项目 2018 2019 2020 2021 2022 2023 2024 2025
流动资产总额 104.30M172.79M377.83M305.52M288.77M230.81M645.82M702.77M
现金及短期投资 78.34M140.55M335.22M239.13M213.14M133.76M535.55M583.76M
存货 2.06M4.04M5.31M10.27M15.16M13.97M14.04M21.63M
总资产 117.52M306.21M511.74M462.97M448.22M433.14M931.45M1.02B
流动负债总额 30.33M52.07M65.67M87.85M89.10M107.37M110.92M151.89M
短期负债 --9.86M19.84M22.81M13.03M15.16M15.87M16.69M
长期负债 34.90M32.99M21.34M9.69M34.94M34.95M646.44M649.50M
总负债 65,386,000.00170,803,000.00170,127,000.00183,452,000.00208,410,000.00223,047,000.00840,541,000.00867,296,000.00
股东权益总额 52.14M135.41M341.61M279.52M239.81M210.10M90.91M152.75M
留存收益 -205.83M-260.39M-304.68M-406.05M-522.20M-645.61M-758.90M-803.45M

现金流量表

项目 2018 2019 2020 2021 2022 2023 2024 2025
经营活动现金流 -29.09M-21.86M-13.76M-37.75M-23.01M-50.10M3.39M80.86M
折旧与摊销 2.27M3.45M12.93M16.59M19.61M22.14M25.78M26.48M
自由现金流 -34.27M-42.32M-27.31M-65.82M-52.84M-90.53M-45.55M34.52M
已派股息 ----------------
股票回购/发行 0107.37M206.03M--00-25.00M0
期末现金余额 20.02M20.46M88.63M127.56M78.83M36.17M427.96M244.37M

回报与效率指标

项目 2018 2019 2020 2021 2022 2023 2024 2025
净资产收益率 -72.07-57.49-18.38-32.64-44.73-54.86-75.27-36.57
总资产收益率 -38.19-25.62-10.72-20.80-25.50-28.00-16.60-4.57
投入资本回报率 -45.69-29.39-11.74-23.34-29.45-35.25-20.56-5.93
5年平均净资产收益率 -------44.05-46.09-41.76-45.18-48.81
息税前利润率 -30.63-24.64-15.87-30.92-27.19-24.15-16.88-4.07
自由现金流/营收 --------------4.62
流动比率 3.443.325.753.483.242.155.824.63
速动比率 3.243.165.563.252.951.825.554.34
资产负债率 29.7042.0023.9325.4329.2429.9779.1171.68
长期负债权益比 66.9487.6930.0433.9549.2154.58793.16467.77
利息保障倍数 -14.49-32.17-27.70-85.39-27.01-32.60-7.79-2.31
营收复合年增长率(3年) 59.7349.6138.8229.9024.1922.9422.3922.05
净利润复合年增长率(3年) ----------------
自由现金流复合年增长率(3年) ----------------

✦ 量化营收集中度 计算方式说明

主业突出,长尾分散
  • 在披露的4个业务分部中,Contracted third-party payors是最大的一项,占营收的50.76%。
  • 紧随其后的Centers for Medicare & Medicaid Services占比26.12%,说明主业仍最重要,但并非全部。

营收构成 最近报告期

业务分部

Contracted third-party payors50.76%
Centers for Medicare & Medicaid Services26.12%
Healthcare Institutions16.85%
Non-contracted third-party payors6.27%

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

艾瑞思姆科技 讨论区 0 条评论

发表评论